These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2004727)

  • 1. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields.
    Mahlberg K; Uusitalo RJ; Gebhardt B; Kaufman HE
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(1):69-74. PubMed ID: 2004727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
    Mahlberg K; Uusitalo RJ; Oksala O
    Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine-containing collagen shields suppress corneal allograft rejection.
    Chen YF; Gebhardt BM; Reidy JJ; Kaufman HE
    Am J Ophthalmol; 1990 Feb; 109(2):132-7. PubMed ID: 2301524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of allogeneic corneal grafts in rabbits treated with topically applied cyclosporin A: systemic absorption and local immunosuppressive effect.
    Foets B; Missotten L; Vanderveeren P; Goossens W
    Br J Ophthalmol; 1985 Aug; 69(8):600-3. PubMed ID: 3893529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The collagen shield. A new vehicle for delivery of cyclosporin A to the eye.
    Reidy JJ; Gebhardt BM; Kaufman HE
    Cornea; 1990 Jul; 9(3):196-9. PubMed ID: 2373013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
    Kanpolat A; Batioglu F; Yilmaz M; Akbas F
    CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal graft rejection: a new rabbit model and cyclosporin-A.
    Hunter PA; Garner A; Wilhelmus KR; Rice NS; Jones BR
    Br J Ophthalmol; 1982 May; 66(5):292-302. PubMed ID: 7041957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of trifluridine to human cornea and aqueous using collagen shields.
    Kuster P; Taravella M; Gelinas M; Stepp P
    CLAO J; 1998 Apr; 24(2):122-4. PubMed ID: 9571274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine.
    Gebhardt BM; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(3):319-27. PubMed ID: 8590264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of corneal allograft rejection by cyclosporin A.
    Salisbury JD; Gebhardt BM
    Arch Ophthalmol; 1981 Sep; 99(9):1640-3. PubMed ID: 6169331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits.
    Bell TA; Easty DL; McCullagh KG
    Br J Ophthalmol; 1982 May; 66(5):303-8. PubMed ID: 7041958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit corneal allograft survival following topical administration of cyclosporin A.
    Kana JS; Hoffmann F; Buchen R; Krolik A; Wiederholt M
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):686-90. PubMed ID: 7076412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blood transfusion and cyclosporin on rabbit corneal graft survival.
    Liu EY; Raizman MB; Rosner B; Ihley TM; Foster CS
    Curr Eye Res; 1989 May; 8(5):523-31. PubMed ID: 2661153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor.
    Unterman SR; Rootman DS; Hill JM; Parelman JJ; Thompson HW; Kaufman HE
    J Cataract Refract Surg; 1988 Sep; 14(5):500-4. PubMed ID: 3183930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen corneal shields enhance penetration of topical prednisolone acetate.
    Sawusch MR; O'Brien TP; Updegraff SA
    J Cataract Refract Surg; 1989 Nov; 15(6):625-8. PubMed ID: 2614704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.